Dr. Zelenko appeals to everyone who cares about the COVID-19 situation and is asking to sign a petition to help his treatment protocol get an EUA. Getting an Emergency Use Authorization for the developed COVID-19 treatment protocol is essential to make it accessible to many people suffering from the disease.
The Emergency Use Authorization (EUA) authority allows FDA to help strengthen the nation’s public health protections against chemical, biological, radiological, and nuclear threats by facilitating the availability and use of medical countermeasures needed during public health emergencies.
Under section 564 of the Federal Food, Drug, and Cosmetic Act, the FDA Commissioner may allow unapproved medical products or unapproved uses of approved medical products to be used in an emergency to diagnose, treat, or prevent serious or life-threatening diseases or conditions caused by CBRN threat agents when there are no adequate, approved, and available alternatives.
You can find the petition here.
The Zelenko Protocol has shown an 84% reduction in hospitalizations in COVID-19 cases and a 0.71% death rate in high-risk patients (expected death rate was >5%). HCQ and Zinc may have a prophylactic and/or treatment role in the influenza virus.
Dr. Vladimir (Zev) Zelenko, M.D., is a board-certified family practitioner in Monroe and Monsey, New York. He is highly respected and beloved by his patients. He has a truly unique and out-of-the-box approach to patient care. He focuses on each patient’s physical, emotional, intellectual, and spiritual needs, and attempts to find integrative solutions that address all these important concerns.
He gained wide popularity after the publication of an open letter to DonaldTrump on March 26, 2020. In his letter, Dr. Zelenko emphasizes that he has developed a COVID-19 drug treatment regimen that has an effect already in the pre-hospital period.
Dr. Zelenko is supported by a lot of people, including patients who felt the positive effect of the treatment, other doctors like an infectious disease doctor David Boulware, and doctors from Harvard and Yale medical schools.